The hard part is already done: the expensive phase of a major undertaking is finished, and the company is now in the col
The model's full reasoning — Q3 2018 call → NOWe need to determine if management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with reported results still mostly reflecting the paying phase. Let's analyze the transcript. The company is OGE Energy, with utility OG&E and midstream Enable. Key points: - Sean Trauschke mentions "OG&E's has had a remarkable year. It seems each quarter we are achieving a new milestone on our journey to continually getting better to improve the customer experience with safe, reliable and low-cost energy." That's general. - He mentions "the Sooner scrubber project that has seen 2.8 million hours work with no loss-time accidents." And later: "The Sooner scrubber project is on time and on budget. Unit 1 has been commissioned, Unit 2 is on schedule and slated for completion next month." So the scrubber project is almost done, but Unit 2 not yet complete. That's a major undertaking. But is it finished? Not yet, Unit 2 next month. So heavy phase not fully done. - He mentions "we also completed and placed into service the Windspeed II transmission line, the Covington solar farm." Those are completed. - He mentions "We settled our last rate case in a constructive manner passing through to our customers the benefits of tax reform in a timely fashion." That's regulatory. - He mentions "we once again answer the call to assist with recent hurricane restoration efforts." That's not a major undertaking. - He talks about "continued customer and sales growth" and "economies of our two largest load centers are robust." That's external. - He talks about "the electrification of compressors and processors in the prolific SCOOP and STACK midstream space." That's a growth area. - Regulatory: "We submitted our final integrated resource plan to the OCC in September and at the same time, we had the opportunity to end a costly contract, which necessitates the need for replacement capacity. For reference, our capacity needs are 168 megawatts by the summer of 2019 and 305 megawatts by the summer of 2020, in order to maintain our capacity reserve margin requirements in the SPP. We issued an RFP for these capacity needs. We expect to make approval filing with the OCC in December and a similar filing in Arkansas." So they are in the middle of a capacity need process, not completed.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HUYA | HUYA Inc. | Q4 2023 | 2024-03-19 | C |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| DAL | Delta Air Lines, Inc. | Q2 2023 | 2023-07-13 | A |
| CURV | Torrid Holdings Inc. | Q2 2022 | 2022-09-07 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| HTLF | Heartland Financial USA, Inc. | Q3 2017 | 2017-10-30 | B+ |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| ARCB | ArcBest Corporation | Q4 2016 | 2017-02-08 | C |
IONS · Q1 2017 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the heavy phase of the SPINRAZA program as concluded ("we concluded our costly Phase III program"), with R&D expenses now expected to decline as the company transitions to a multiproduct profitable organization. They note that Q1 marked the first full quarter of commercial revenues ($47 million), with royalties of 5.2 million reflecting the early stage of this new revenue stream, while the reported results still include substantial R&D revenue (102 million) and show profitability driven by the ongoing evolution toward sustained profitability. The commercial benefits are visibly beginning but remain early, with the numbers carrying the burden of the prior development effort.
PKOH · Q3 2022 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the phase where they collect...YES Management describes the restructuring of 14 global locations as "largely completed," with the cycle finished and no significant customer attrition. They are now pivoting to focus on the balance sheet and "harvesting some of the significant cash investments" made over the last couple of years, while noting that earnings are continuing to improve sequentially in Q4 despite inflation. The reported results show positive cash flow and improved metrics, but the harvest is described as beginning, with the $60 million working capital investment expected to convert over 12-18 months, indicating the collecting phase is early and the numbers still largely reflect the prior paying phase.
AKYA · Q2 2023 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the first phase (2021–end of 2022) as having completed its core objectives: successful launch of Fusion, portfolio development, organizational expansion, and platform enhancements. They explicitly frame the second phase as now beginning, with the reported Q2 results still carrying the burden of that prior heavy investment (high OpEx, RIF charges, gross-margin pressure) while the new phase is visibly starting to deliver through record revenue, reagent pull-through, and cost-optimization moves. The numbers lag the crossing, as the company is still pre-profitability and targeting cash-flow positivity only in 2025.